Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A complex immune-mediated process triggered by restoration of blood flow after ischemia. Characterized by rapid recruitment/activation of immune cells releasing pro-inflammatory cytokines/chemokines and reactive oxygen species that exacerbate tissue damage. Essential for clearing dead/damaged cells but often becomes maladaptive in I/R settings—leading instead to increased cell death/tissue dysfunction.
Modulation of cytokine signaling, reduction of oxidative stress, inhibition of leukocyte recruitment and activation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inflammatory Response (Reperfusion Injury) (None).